Cue Biopharma, Inc. (CUE) Current Reports & Earnings Releases
Upcoming
- 2026-11-11 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-14 | 8-K | Results of Operations | SEC |
| 2026-08-03 | 8-K | Officer / Director Changes | SEC |
| 2026-07-10 | 8-K | Material Agreement, Unregistered Sales, Officer / Director Changes, Other Events, Financial Statements & Exhibits | SEC |
| 2026-06-03 | 8-K | Officer / Director Changes, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2026-06-02 | 8-K | Officer / Director Changes, Other Events | SEC |
| 2026-05-14 | 8-K | Financial Statements & Exhibits | SEC |
| 2026-05-01 | 8-K | Material Agreement, Unregistered Sales, Officer / Director Changes, Other Events, Financial Statements & Exhibits | SEC |
| 2026-04-22 | 8-K | Item 3.03, Charter Amendments | SEC |
| 2026-04-13 | 8-K | Shareholder Vote Results | SEC |
| 2026-04-07 | 8-K | Other Events | SEC |
| 2026-03-27 | 8-K | Officer / Director Changes | SEC |
| 2026-03-16 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-02-18 | 8-K | Other Events | SEC |
| 2026-02-12 | 8-K | Officer / Director Changes | SEC |
| 2025-12-19 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2025-11-24 | 8-K | Reg FD Disclosure | SEC |
| 2025-11-20 | 8-K | Officer / Director Changes | SEC |
| 2025-11-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-11-06 | 8-K | Material Agreement, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-09-29 | 8-K | Officer / Director Changes | SEC |
| 2025-08-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-07-01 | 8-K | Material Agreement | SEC |
| 2025-06-10 | 8-K | Officer / Director Changes, Charter Amendments, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2025-05-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-04-15 | 8-K | Material Agreement, Results of Operations, Other Events, Financial Statements & Exhibits | SEC |
| 2025-04-14 | 8-K | Material Agreement | SEC |
| 2025-03-31 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-03-12 | 8-K | Officer / Director Changes | SEC |
| 2024-11-14 | 8-K | Results of Operations | SEC |
| 2024-10-08 | 8-K | Charter Amendments, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2024-10-04 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2024-09-27 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2024-09-03 | 8-K | Officer / Director Changes | SEC |
| 2024-08-16 | 8-K | Listing Notice | SEC |
| 2024-07-25 | 8-K | Officer / Director Changes, Other Events, Financial Statements & Exhibits | SEC |
| 2024-06-07 | 8-K | Officer / Director Changes, Shareholder Vote Results | SEC |
| 2024-05-09 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.